These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. High-dose intravenous immunoglobulin therapy for myasthenia gravis. Jongen JL; van Doorn PA; van der Meché FG J Neurol; 1998 Jan; 245(1):26-31. PubMed ID: 9457625 [TBL] [Abstract][Full Text] [Related]
7. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis. Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536 [TBL] [Abstract][Full Text] [Related]
8. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status. Illa I J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667 [TBL] [Abstract][Full Text] [Related]
10. Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin. Gajdos P; Chevret S Ann N Y Acad Sci; 2008; 1132():271-5. PubMed ID: 18096850 [TBL] [Abstract][Full Text] [Related]
11. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic. Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838 [TBL] [Abstract][Full Text] [Related]
12. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients. Alipour-Faz A; Shojaei M; Peyvandi H; Ramzi D; Oroei M; Ghadiri F; Peyvandi M Acta Neurol Belg; 2017 Mar; 117(1):245-249. PubMed ID: 27530310 [TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis. Yasuda M; Uzawa A; Ozawa Y; Kojima Y; Onishi Y; Akamine H; Kuwabara S Scand J Immunol; 2022 Feb; 95(2):e13122. PubMed ID: 34796975 [TBL] [Abstract][Full Text] [Related]
15. Comparison of IVIg and PLEX in patients with myasthenia gravis. Barth D; Nabavi Nouri M; Ng E; Nwe P; Bril V Neurology; 2011 Jun; 76(23):2017-23. PubMed ID: 21562253 [TBL] [Abstract][Full Text] [Related]
16. [Contribution of intravenous immunoglobulins to the treatment of myasthenia]. Gajdos P Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S30-4. PubMed ID: 10896986 [TBL] [Abstract][Full Text] [Related]
18. IVIG and PLEX in the treatment of myasthenia gravis. Bril V; Barnett-Tapia C; Barth D; Katzberg HD Ann N Y Acad Sci; 2012 Dec; 1275():1-6. PubMed ID: 23278570 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R; Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163 [TBL] [Abstract][Full Text] [Related]